Last reviewed · How we verify
Xylitol syrup — Competitive Intelligence Brief
phase 3
sugar substitute
Dentistry
Small molecule
Live · refreshed every 30 min
Target snapshot
Xylitol syrup (Xylitol syrup) — Boston Children's Hospital. Xylitol syrup works by inhibiting the growth of bacteria in the mouth, thereby preventing tooth decay.
Comparator set (1 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Xylitol syrup TARGET | Xylitol syrup | Boston Children's Hospital | phase 3 | sugar substitute | ||
| Xylitol Gum | Xylitol Gum | West Virginia University | phase 3 | Sugar substitute |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (sugar substitute class)
- Boston Children's Hospital · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Xylitol syrup CI watch — RSS
- Xylitol syrup CI watch — Atom
- Xylitol syrup CI watch — JSON
- Xylitol syrup alone — RSS
- Whole sugar substitute class — RSS
Cite this brief
Drug Landscape (2026). Xylitol syrup — Competitive Intelligence Brief. https://druglandscape.com/ci/xylitol-syrup. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab